{"summary":"Keywords: Immunology, oncology, Ph.D., Scientist, Sr. Scientist, Flow Cytometry, In vivo Models, in vitro assays, T cells, immunogenicity, DCs, Translational research.\n\nSummary: \n1. Passionate and highly motivated scientist with 7+ years of experience in immunology-related research in cancer and inflammation diseases, with a solid background in biochemistry and molecular biology skillset and in vivo models. \n2. Versatile Ph.D. focusing on T-cell-based immune therapy and new developments (CAR-T, ADC, Engager, etc). \n3. Demonstrated interpersonal, communication, and collaboration skills; served as both leader and collaborator in multiple projects with peer-reviewed publications.\n\nMain experience:\n1: investigating cancer T-cell crosstalk in solid tumors. Hands-on experience in T-cell isolation, activation, and characterization. Expert in assays checks T-cell secretome (ELISA, MSD), cytotoxicity (In vitro), and immune cell infiltration (in vivo, FACS panel design\/optimization, stain, data acquisition, and analysis). Experienced with DC cell culture and antigen presentation to T-cells.\n\n2: investigating how immune-regulator protein PGRN impacts influenza virus infection and NK cell recruitment in melanoma. Expert in gene editing with lentivirus systems and siRNA, etc. I worked in the Car-T design lab, which targeted Mesothelin in TNBC and depleted PD-1 in Car-T cells using the CRISPR-Cas9 system.\n\n3: other research experiences include A: synthetic biology circuit design in iGEM, B: Biomarker development with patient serum and tissue lysates, C: antibody generation with purified protein immunization to rabbits, D: RNA degradation mechanism study with Yeast (S. cerevisiae), E: internship in structural biology lab and medical isotope conjugation lab for both imaging and therapy.\n\n4: leadership role: A: Student Representative of BMB PhD program, a) Orgazning student monthly meetings (agenda including mentoring juniors about fellowship, comprehensive exams, networking, and scientific discussion)  b.) Invited Dr. David Tuveson, former AACR president, for seminar and student interaction events. B: Student ambassador for connecting UNMC-JLU and JLU-Queens University Belfast, introducing each university and facilitating exchange business developments. C: Active member of Nebraska Entrepreneur Club, Bio Nebraska, AACR-scholar-in-training award alumni, UCLA-cross-disciplinary Scholars in Science and Technology (CSST) alumni, JLU-Rutgers University Summer Exchange alumni, JLU-University of Manchester exchange alumni, SJTU-Taiwan winter camp alumni.","lastName":"LI","objectUrn":"urn:li:member:325794911","geoRegion":"Omaha, Nebraska, United States","fullName":"XIAOQI(Kevin) LI","firstName":"XIAOQI(Kevin)","currentPositions":[{"companyName":"University of Nebraska Medical Center","description":"\u2022\tDesigned patient-wise manner correlation analysis for T-cell subpopulation genes and mucin expression using publicly available scRNA-seq data (computational analysis)\n\u2022\tAnalyzed how T-cell secretome regulates mucin RNA, protein, and glycan changes via primary T cell culture and cell line-based assays (involved high throughput lectin array analysis for glycan changes) (Collaborated with Dr. Brian Haab from Van Andel Institute)\n\u2022\tPerformed RNA-seq-based transcriptomic analysis with T-cell secretome-treated cancer cells, narrowing down to immune cell-mediated cell death and resistance-associated pathways. \n\u2022\tExamined how MUC4 expression impacts T-cell infiltration in vivo (allograph model, FACS analysis, and tissue analysis) and T-cell-induced cytotoxicity in vitro (FACS and biochemistry analysis) with generated CRISPR\/Cas9-KO cell lines\n\u2022\tInspected mechanism of action: how MUC4 protects cancer cells from T-cell secretome-mediated cell death with designed immunoprecipitation, size exclusion column, ELISA, and immunofluorescence assays. \n\u2022\tAchieved regional and national meeting presentations with awards and publications.\n\u2022\tClinical relevance: T-cell-based immunotherapy in mucin-expressing cancers (pancreatic, ovarian, lung, bladder, lung, colon etc) need to consider stratifying patients according to mucin levels to reduce potential acquired resistance.","title":"Research Assistant","companyUrnResolutionResult":{"employeeCountRange":"1001-5000","headquarters":{"geographicArea":"Nebraska","country":"United States","city":"Omaha","postalCode":"68198-7815","line1":"987815 Nebraska Medical Ctr"},"website":"http:\/\/unmc.edu","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/university-of-nebraska-medical-center\/","industry":"Higher Education"},"companyUrn":"urn:li:fs_salesCompany:14114","tenureAtCompany":{"numYears":4,"numMonths":5},"startedOn":{"month":1,"year":2020}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1710179435976?e=1723075200&v=beta&t=4HOaSuHAmWvcH7vav5uqOrm73HK_AdmeeUz7Ns7hELo","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1710179435976?e=1723075200&v=beta&t=HR9HDwnMzaMvWoszM4iPb6l0SzbwjCwSi_Q-rgF84NI","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1710179435976?e=1723075200&v=beta&t=1b2LJ57FN4GQijU425-dESsW8fXLCB29vPRwYW5ztZg","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1710179435976?e=1723075200&v=beta&t=mPgjc2eK8UwqW9oHR0_1UKiGTEQlg9UtvbT6HtQf0Xc","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D5603AQEJ7Suu26vKFg\/profile-displayphoto-shrink_"},"projects":[{"endedOn":{"month":11,"year":2014},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}],"description":"For international Genetically Engineering Machine Competition (iGEM), Silver Medal as a Group. ","title":" Biodetection and biodegradation of Microcystin LR","startedOn":{"month":10,"year":2013}},{"endedOn":{"month":3,"year":2015},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}],"description":"National University Student Innovation Program","title":"Preparation and preliminary identification of the monoclonal antibody against NS3 protein in GB virus C","startedOn":{"month":3,"year":2014}},{"endedOn":{"month":9,"year":2015},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}],"description":"CSST Program","title":"Nuclear RNA Degradation of the SMF1 Metal Transporter During Heavy Metal Toxicity","startedOn":{"month":7,"year":2015}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}],"description":"Pancreatic cancer is one of the leading causes of cancer death in the U.S., with 5-year survival less than 10%. MUC4 and MUC5AC, two members of the mucin glycoprotein family, are abnormally expressed in early pancreatic intracellular neoplasia (PanIN) lesions. Their expressions are strongly associated with pancreatic cancer initiation, progression, and metastasis.  Here we try to find out the role of IL-17 secreting cells in the mucin expression regulation, and how these expression changes would change the progression of pancreatic cancer and T cell function, aka, the cross-talk between the cancer cells and immune cells.","title":"the IL-17-Mucin axis in pancreatic cancer progression and cancer-T cell crosstalk","startedOn":{"month":3,"year":2020}},{"endedOn":{"month":1,"year":2019},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}],"description":"progranulin, the regulatory protein in the immune system plays a significant role in inflammation diseases. influenza infection also associated with inflammation and other immune responses. we try to identify the function of progranulin in influenza virus infection. Via utilizing a virus-like particle system, we verified the role of progranulin in influenza A virus infection, specifically the entry step.","title":"The mechanism study of progranulin facilitating Influenza A virus (H1N1) infection","startedOn":{"month":3,"year":2017}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}],"title":"T cell secretome modified tumor micro environmental via changing protein glycosylation ","startedOn":{"month":8,"year":2020}}],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2024},"degree":"Doctor of Philosophy - PhD","eduId":596239895,"schoolUrn":"urn:li:fs_salesSchool:14114","school":"urn:li:fs_salesSchool:14114","fieldsOfStudy":["Biomedical Science"],"schoolName":"University of Nebraska Medical Center","startedOn":{"year":2019}},{"endedOn":{"year":2019},"degree":"Master's degree","eduId":497471828,"schoolUrn":"urn:li:fs_salesSchool:27413","school":"urn:li:fs_salesSchool:27413","fieldsOfStudy":["immunology (genetics & developmental biology)"],"schoolName":"Shanghai Jiao Tong University","startedOn":{"year":2016}},{"endedOn":{"year":2016},"degree":"Bachelor's degree","eduId":208930329,"schoolUrn":"urn:li:fs_salesSchool:103242","school":"urn:li:fs_salesSchool:103242","fieldsOfStudy":["Biology, General"],"schoolName":"Jilin University","startedOn":{"year":2012}},{"endedOn":{"year":2016},"degree":"No degree","eduId":307806698,"schoolUrn":"urn:li:fs_salesSchool:166652","school":"urn:li:fs_salesSchool:166652","fieldsOfStudy":["Biochemistry"],"schoolName":"The University of Manchester","startedOn":{"year":2015}},{"endedOn":{"year":2015},"degree":"No degree","eduId":208930277,"schoolUrn":"urn:li:fs_salesSchool:2477","school":"urn:li:fs_salesSchool:2477","fieldsOfStudy":["Chemistry and Biochemistry"],"schoolName":"University of California, Los Angeles","startedOn":{"year":2015}}],"skills":[{"numOfEndorsement":0,"name":"Toxicity"},{"numOfEndorsement":0,"name":"Protein Conjugation"},{"numOfEndorsement":0,"name":"radiotherapy"},{"numOfEndorsement":0,"name":"High-Performance Liquid Chromatography (HPLC)"},{"numOfEndorsement":0,"name":"Crystallization"},{"numOfEndorsement":0,"name":"PDB"},{"numOfEndorsement":0,"name":"Pymol"},{"numOfEndorsement":0,"name":"Public Speaking"},{"numOfEndorsement":0,"name":"Time Management"},{"numOfEndorsement":0,"name":"Team Leadership"},{"numOfEndorsement":0,"name":"Conflict Resolution"},{"numOfEndorsement":0,"name":"Mentoring"},{"numOfEndorsement":0,"name":"Event Planning"},{"numOfEndorsement":0,"name":"FlowJo"},{"numOfEndorsement":0,"name":"Cryopreservation"},{"numOfEndorsement":0,"name":"Oral Communication"},{"numOfEndorsement":0,"name":"GraphPad Prism"},{"numOfEndorsement":0,"name":"Responsible Conduct of Research"},{"numOfEndorsement":0,"name":"Mice handing"},{"numOfEndorsement":0,"name":"Presentations"},{"numOfEndorsement":0,"name":"Cancer Immunotherapy"},{"numOfEndorsement":0,"name":"Primary Cell Isolation"},{"numOfEndorsement":0,"name":"In Vivo"},{"numOfEndorsement":0,"name":"In Vitro"},{"numOfEndorsement":0,"name":"Technical Proficiency"},{"numOfEndorsement":0,"name":"Scientific Research"},{"numOfEndorsement":0,"name":"Communication"},{"numOfEndorsement":0,"name":"Research Projects"},{"numOfEndorsement":0,"name":"Timelines"},{"numOfEndorsement":1,"name":"Primary T cell culture"},{"numOfEndorsement":1,"name":"Primary DCs induction"},{"numOfEndorsement":1,"name":"Multi-color Flow Cytometry"},{"numOfEndorsement":1,"name":"Cytokine beads array analysis"},{"numOfEndorsement":1,"name":"IHC"},{"numOfEndorsement":1,"name":"GEMM colony breeding"},{"numOfEndorsement":1,"name":"Mice immune phenotyping"},{"numOfEndorsement":1,"name":"R (Programming Language)"},{"numOfEndorsement":5,"name":"Molecular Biology"},{"numOfEndorsement":5,"name":"Cell Biology"},{"numOfEndorsement":5,"name":"Cell Culture"},{"numOfEndorsement":1,"name":"Flow Cytometry"},{"numOfEndorsement":3,"name":"PCR"},{"numOfEndorsement":5,"name":"Western Blotting"},{"numOfEndorsement":1,"name":"shRNA KD"},{"numOfEndorsement":1,"name":"siRNA KD"},{"numOfEndorsement":1,"name":"qRT-PCR"},{"numOfEndorsement":3,"name":"Protein Chemistry"},{"numOfEndorsement":1,"name":"lentivirus overexpression"},{"numOfEndorsement":1,"name":"Ni-NTA protein purification"},{"numOfEndorsement":5,"name":"Biochemistry"},{"numOfEndorsement":3,"name":"Life Sciences"},{"numOfEndorsement":4,"name":"Laboratory"},{"numOfEndorsement":5,"name":"Microsoft Office"},{"numOfEndorsement":2,"name":"Microsoft Excel"},{"numOfEndorsement":2,"name":"Data Analysis"},{"numOfEndorsement":1,"name":"Transgenic Mice"},{"numOfEndorsement":1,"name":"Immunology"},{"numOfEndorsement":1,"name":"PCR Primer Design"},{"numOfEndorsement":1,"name":"Real-Time Polymerase Chain Reaction (qPCR)"},{"numOfEndorsement":1,"name":"Protein Purification"},{"numOfEndorsement":1,"name":"ELISA"},{"numOfEndorsement":1,"name":"Cancer Research"},{"numOfEndorsement":1,"name":"Immunohistochemistry"}],"pronoun":"He\/Him","numOfConnections":1152,"patents":[],"headline":"Ph.D. @UNMC| UCLA\/UoManchester\/SJTU\/JLU Alumni| T-cell Scientist focusing on Cancer\/Inflammation diseases","courses":[],"certifications":[{"authority":"World Education Services (WES)","name":"Verified International Academic Qualifications","licenseNumber":"wes-16229097","startedOn":{"month":2,"year":2019},"url":"https:\/\/t.cred.ly\/wrMuMM3wxlF95VeKP4s2mg,,$$$KxZ6NZa_nMsY3bKRrnDVr-t1OGH95MJPnNydDs0v-Yl7I4AyUuA0pLeXxmydNUOKnEKwnyTNkH0E6sKvQ9QpJ3Bne0UyJSuN08HhxmFl0BE,?r=https%3A%2F%2Fwes.credly.com%2Fmember-badges%2F16229097&t=1548987640"},{"authority":"University of Nebraska Medical Center","name":"Teaching Certificate ","company":"urn:li:fs_salesCompany:14114","startedOn":{"month":4,"year":2021},"companyUrn":"urn:li:fs_salesCompany:14114"},{"companyUrn":"urn:li:fs_salesCompany:11118398","url":"https:\/\/www.citiprogram.org\/verify\/?w21be153c-dfa3-4fdb-a4d8-fa82bd0f0d2a-34628254","authority":"CITI Program","name":"Working with Mice in Research Settings","company":"urn:li:fs_salesCompany:11118398","licenseNumber":"34628254","startedOn":{"month":1,"year":2020}},{"companyUrn":"urn:li:fs_salesCompany:11118398","url":"https:\/\/www.citiprogram.org\/verify\/?w0699b25a-bc51-481e-9b3c-4e3e054b6ea0-33471636","authority":"CITI Program","name":"Responsible Conduct of Research","company":"urn:li:fs_salesCompany:11118398","licenseNumber":"33471636","startedOn":{"month":1,"year":2020}},{"authority":"Partners for Advancing Clinical Education (PACE)","name":"Advances in Cancer Immunotherapy -A focus on Toxicity Management. ","startedOn":{"month":5,"year":2024}}],"memberBadges":{"premium":true,"openLink":true,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/xiaoqi-kevin-li-87b13691","organizations":[{"name":"American Pancreatic Association ","startedOn":{"month":11,"year":2022}},{"name":"American Association of Cancer Research ","startedOn":{"month":11,"year":2023}}],"location":"Omaha, Nebraska, United States","publications":[{"publishedOn":{"month":11,"day":28,"year":2019},"description":"I contributed to the analysis of Immune cells, specifically, Natural Killer Cells in the B16-F10 allograph melanoma murine models. This work facilitated the understanding of progranulin function in cancer and provided new potential targets for melanoma treatment.","url":"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0304383519304550","name":"Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment","publisher":"Elsevier","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}]},{"publishedOn":{"month":8,"day":27,"year":2022},"description":"Review article talking about why immune therapy did not work in pancreatic cancer (PC), the regulation network of Immune checkpoints in PC  and possible combination therapies.","url":"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1044579X2200195X","name":"Immune checkpoint blockade in pancreatic cancer: trudging through the immune desert","publisher":"Seminars in Cancer Biology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}]},{"publishedOn":{"month":3,"day":22,"year":2022},"description":"Review article describing the cytokines in pancreatic cancer and therapy functions in cancer initiation, progression, and metastasis.","url":"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1044579X22000773","name":"Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment","publisher":"Seminars in Cancer Biology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}]},{"publishedOn":{"month":1,"day":9,"year":2023},"description":"We discovered that MUC4, a biomarker glycoprotein in pancreatic cancer, can stabilize EGFR signaling in a ligand-dependent manner, contributing to early pancreatic cancer tumorigenesis. I contributed to the mice model generation\/colony breeding and several biochemistry-based experiments, such as Western blot, immunohistochemistry, etc.","url":"https:\/\/www.nature.com\/articles\/s41388-022-02587-1","name":"Muc4 loss mitigates epidermal growth factor receptor activity essential for PDAC tumorigenesis","publisher":"Oncogene","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}]},{"publishedOn":{"month":3,"day":22,"year":2024},"description":"AACR annual meeting abstract depicting my main PhD thesis work. It unveiled a novel MUC4-mediated T-cell therapy resistance mechanism. With this mechanism in mind, potential T-cell therapies in pancreatic, bladder, colon, ovarian, lung, and stomach cancers should consider the potential pro-tumor role of MUC4 induced by T-cell secretome.","url":"https:\/\/aacrjournals.org\/cancerres\/article\/84\/6_Supplement\/1594\/737394","name":"Abstract 1594: Pancreatic cancer and T-cell crosstalk-induced MUC4 expression attenuates T-cell-mediated response","publisher":"Cancer Research","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}]},{"name":"SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4\/XRCC4\/XLF complex in non-homologous end joining repair","publisher":"Oncogenesis","url":"https:\/\/www.nature.com\/articles\/s41389-023-00503-0","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAABNrPF8BivgB3xs1PpoMCCbbNKqzp1FxybU,NAME_SEARCH,j0ab)"}]}],"positions":null,"posts":[{"createdAt":1715964840000,"insightId":"ec371e39-766e-44a7-abed-c7bf1d482201","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D5610AQHKMehM1Pt7vw\/image-shrink_1280\/0\/1715964845041?e=1717977600&v=beta&t=GjPlmL2aAAJRoexFeD4ESfF6q9WVo97lyOh_T-jdLtM"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":24}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7197278216657514496","threadUrn":"urn:li:activity:7197278216657514496","reactionsCount":24,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7197278212974891009","message":{"attributes":[{"start":47,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:nih"}}},{"start":328,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:supportive"}}},{"start":500,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:jobhunting"}}}],"text":"\ud83c\udf89 Just had an incredible experience attending #NIH Career Symposium 2024! \ud83c\udf89  - I remember attending these events in 2020 when COVID-19 hints. And my iPad still has so many screenshots to refer to when I need them recently. This year, I am more experienced and more focused. I am glad to meet so many euthanasic, friendly, and #supportive people. You guys are the best. Listened to stories, suggestions, and comments about so many things. All information will be incorporated into my experience and #jobhunting. Good luck to everyone at the symposium. I highly recommend it to junior trainees."},"entityUrn":"urn:li:share:7197278212974891009"}}},{"createdAt":1715451180000,"insightId":"d58d9835-d1cb-4e36-acfb-5ca4031ffd66","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7195123775317716992","threadUrn":"urn:li:ugcPost:7195123775317716992","reactionsCount":1,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7195123775317716992","message":{"attributes":[],"text":"Interesting ideas \ud83d\udca1 and worth reading \ud83d\udc4d\ud83d\udc4d\ud83d\udc4d"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"title":{"text":"Rapid manufacturing of non-activated potent CAR T cells"},"mediaType":"PAGINATEDDOCUMENT"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7194720754247090177","message":{"attributes":[{"start":1166,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/ghcFXduM"}}}],"text":"Rapid manufacturing of non-activated potent CAR T cells\nChimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell haematologic malignancies. The manufacturing of these T cells typically involves their activation, followed by viral transduction and expansion ex vivo for at least 6\u2009days. However, the activation and expansion of CAR T cells leads to their progressive differentiation and the associated loss of anti-leukaemic activity. Here we show that functional CAR T cells can be generated within 24\u2009hours from T cells derived from peripheral blood without the need for T-cell activation or ex vivo expansion, and that the efficiency of viral transduction in this process is substantially influenced by the formulation of the medium and the surface area-to-volume ratio of the culture vessel. In mouse xenograft models of human leukaemias, the rapidly generated non-activated CAR T cells exhibited higher anti-leukaemic in vivo activity per cell than the corresponding activated CAR T cells produced using the standard protocol. The rapid manufacturing of CAR T cells may reduce production costs and broaden their applicability.\n\nhttps:\/\/lnkd.in\/ghcFXduM"},"entityUrn":"urn:li:ugcPost:7194720754247090177"},"entityUrn":"urn:li:ugcPost:7195123775317716992"}}},{"createdAt":1712935980000,"insightId":"f42134a9-e2df-46e6-9356-4c3aa6aa6da3","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":4},{"type":"PRAISE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7184574363512270848","threadUrn":"urn:li:ugcPost:7184574363512270848","reactionsCount":5,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7184574363512270848","message":{"attributes":[{"start":16,"length":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:platform"}}},{"start":166,"length":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:nebraska"}}},{"start":314,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:opportunities"}}}],"text":"This is a great #platform for connections and building up new collaborations. Nebraska is a land with kind people and excellent opportunities. Like in the old times, #Nebraska could be a great connecting point between coasts and serving the greater Midwest people. Stay tuned with BioNebraska for more updates and #opportunities.\u00a0I am privileged to be part of the community and connect with it. BTW, I am amazed by the location, a production line for their own brewing beer. If you have a chance, try it at Pint nine. "},"rootActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:multiPhoto:1000158418058"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7184549286339055617","message":{"attributes":[{"start":173,"length":15,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:35683464"}}},{"start":352,"length":17,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:29017550"}}},{"start":371,"length":8,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:905785"}}},{"start":381,"length":43,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:10195160"}}},{"start":426,"length":6,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:53466"}}},{"start":434,"length":5,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1486"}}},{"start":441,"length":33,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:119184"}}},{"start":503,"length":2,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:3102"}}},{"start":507,"length":18,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:394497"}}},{"start":527,"length":3,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:17043"}}},{"start":532,"length":15,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:6465483"}}},{"start":549,"length":29,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:5921"}}},{"start":580,"length":27,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:5772"}}},{"start":636,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:101346160"}}},{"start":647,"length":15,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1561283"}}},{"start":664,"length":8,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1406"}}},{"start":674,"length":51,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:22347268"}}},{"start":727,"length":14,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:58111"}}},{"start":743,"length":5,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1893"}}},{"start":787,"length":6,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:53466"}}},{"start":795,"length":2,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:3102"}}},{"start":799,"length":33,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:119184"}}},{"start":871,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:101346160"}}},{"start":881,"length":3,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:17043"}}},{"start":886,"length":15,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1561283"}}},{"start":903,"length":15,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:6465483"}}},{"start":920,"length":5,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1893"}}},{"start":927,"length":18,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:394497"}}}],"text":"Thank you to everyone who came out last night to Bio & Beers at Pint Nine Brewing! It was a great night to connect with Nebraska's bioscience industry, as well as hear from GMP Pros, Inc.\u00ae, this month's Bio Nebraska Member Spotlight company. \n\nLast but not least, thank you to all of our sponsors for supporting Bio & Beers! \n\nGold Corporate Sponsors: Fisher Scientific, Celerion, Nebraska Department of Economic Development, Streck, Merck, McCarthy Building Companies, Inc.\n\nSilver Corporate Sponsors: BD, Neogen Corporation, CRB, HUVEPHARMA, INC, University of Nebraska System, Turner Construction Company\n\nBronze Corporate Sponsors: Novonesis, MMC Contractors, Novartis, Lincoln Partnership for Economic Development (LPED), Baird Holm LLP, Bayer\n\nSilver Women in Bioscience Sponsors: Streck, BD, McCarthy Building Companies, Inc.\n\nBronze Women in Bioscience Sponsors: Novonesis\nCRB, MMC Contractors, HUVEPHARMA, INC, Bayer, Neogen Corporation"},"entityUrn":"urn:li:ugcPost:7184549286339055617"},"entityUrn":"urn:li:ugcPost:7184574363512270848"}}},{"createdAt":1712891880000,"insightId":"366a9547-0e3a-40b4-a7c9-92f91b5e4c35","activityUnion":{"postActivity":{"contentSummaryUnion":{"referenceContentSummary":{"entityUrn":"urn:li:multiPhoto:1000149577684"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":80},{"type":"PRAISE","count":18}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7184389481410490369","threadUrn":"urn:li:ugcPost:7184389481410490369","reactionsCount":98,"commentsCount":9,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7184389481410490369","message":{"attributes":[{"start":51,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:aacr24"}}},{"start":451,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:connect"}}},{"start":644,"length":9,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:platform"}}},{"start":658,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:collaboration"}}},{"start":711,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:mentors"}}},{"start":859,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:729778013"}}},{"start":908,"length":20,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:506338312"}}},{"start":948,"length":19,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:660764152"}}}],"text":"Overwhelmed, mind-blowing, privileged. 3 words for #AACR24. Meeting so many oncologists simultaneously, learning so many ideas through posters, symposiums, and discussions, and establishing connections with great people who share the same enthusiasm are wonderful.\nSeveral points: Thanks for the support from the AACR travel award, mentors, and peers for providing this fantastic opportunity and contributing to the research work. I was privileged to #connect with this group of young scientists pursuing different perspectives of cancer while aiming for the same, better patient welfare and ending cancer. Meanwhile, this is also an excellent #platform for #collaboration, exchanging ideas, and meeting career #mentors and online role models in person. Thanks to all the people interested in the work and visiting the poster. Thanks to local college friends Yuwenbin Li, local community friends, lab alumni Koelina Ganguly, PhD, and close friends Clara Sophia Mundry for guidance, discussion, and support during the meeting. \nI regret not having the chance to take so many pictures while I am a bad selfie-taker. But I have noted the contact info. Please keep in touch with me. I hope all of my old and new friends have a successful career. "},"entityUrn":"urn:li:ugcPost:7184389481410490369"}}},{"createdAt":1711663680000,"insightId":"fb161140-852e-41a3-a127-9723f6c49aa8","activityUnion":{"postActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D4E22AQETEloBkLP_5Q\/feedshare-shrink_2048_1536\/0\/1711663711904?e=1720051200&v=beta&t=4ppxdKZSgfKZmnFvSQyjPkcqRSLdIassxkqkixRV-os"}},"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":69},{"type":"PRAISE","count":9},{"type":"EMPATHY","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7179237959269789696","threadUrn":"urn:li:activity:7179237959269789696","reactionsCount":79,"commentsCount":17,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7179237958120558592","message":{"attributes":[{"start":109,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:aacr24"}}},{"start":124,"length":17,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:pancreaticcancer"}}},{"start":198,"length":19,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:acquiredresistance"}}},{"start":221,"length":6,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:tcell"}}},{"start":228,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:immunotherapy"}}},{"start":359,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:alumni"}}},{"start":549,"length":6,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:award"}}},{"start":569,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:defend"}}},{"start":669,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:opentowork"}}},{"start":734,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:immunooncology"}}}],"text":"T-cell-mediated acquired resistance in cancer- the topic I will present at the AACR annual meeting next week #AACR24. Using #pancreaticcancer models, this study addresses the unique role of MUC4 in #acquiredresistance in #Tcell #Immunotherapy.  Please come and talk to me if interested. Research scientists, journal editors, industrial recruiters, and school #alumni, are all welcomed. Meanwhile, I want to thank the support from the department, my supervisor, Dr. Surinder Batra and Dr. Sushil Kumar, my lab peers, and the AACR scholar-in-training #award. BTW, I will #defend my thesis next Thursday, so good luck to myself. I can share a link if interested. And I am #OpenToWork for scientist\/senior scientist jobs, associated with #immunooncology, biochemistry, and molecular biology. please comment and repost if your network will help. Thank you in advance. "},"entityUrn":"urn:li:share:7179237958120558592"}}},{"createdAt":1711590600000,"insightId":"d85f5c0a-c052-4fbe-b949-de16e41cd41f","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":4}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:activity:7178931522702336000","threadUrn":"urn:li:activity:7178931522702336000","reactionsCount":4,"commentsCount":0,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7178931521997733888","message":{"attributes":[],"text":"What a fantastic work! Key data in mind: CD8 cells were IF\u039d-\u03b3 alone(33.5%), TNF-\u03b1 alone (4.29%), IFN-\u03b3 and TNF-\u03b1 simultaneously (24%). Meanwhile, here are key follow-up questions: 1: IFN-\u03b3 and TNF-\u03b1 could lead to potential resistant mechanisms against T-cell-based immunotherapy. How can we balance that while using these cytokines as the key marker? (for sure, we need workable TCR-T first) 2: When checking the killing effects, how do we narrow it down to Granzyme? Reference 15 discussed the collaborative roles of both Perforin and Granzyme. Are there any interesting details about choosing granzyme as the marker instead of both? Congratulations to this fantastic team!"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"mediaType":"STILLIMAGE","thumnailUrl":"https:\/\/media.licdn.com\/dms\/image\/D5622AQGUV8634quQpg\/feedshare-shrink_2048_1536\/0\/1711574971766?e=1720051200&v=beta&t=UMdPam_7ui3AwR6xRMGtbywns19kdhwGYsMW7gdsjtM"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:share:7178865756560920576","message":{"attributes":[{"start":101,"length":28,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:8416"}}},{"start":293,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:nanovials"}}},{"start":501,"length":23,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:912221"}}},{"start":661,"length":12,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:3684165"}}},{"start":743,"length":9,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:442495"}}},{"start":1237,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:celltherapies"}}},{"start":1342,"length":21,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:67546336"}}},{"start":1367,"length":12,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:celltherapy"}}},{"start":1380,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:biotechnology"}}},{"start":1395,"length":7,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:tcells"}}},{"start":1403,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:immunotherapy"}}},{"start":1418,"length":5,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:tcrs"}}},{"start":1424,"length":15,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:labonaparticle"}}},{"start":1440,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:cytometry"}}},{"start":1451,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:flowcytometry"}}},{"start":1466,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:singlecell"}}},{"start":1478,"length":14,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:functionfirst"}}},{"start":1513,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:344375188"}}},{"start":1635,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:326146142"}}},{"start":1649,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:240756089"}}},{"start":1666,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:493315034"}}},{"start":1679,"length":17,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:904489020"}}},{"start":1698,"length":14,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:618406557"}}},{"start":1761,"length":31,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:3424"}}},{"start":1810,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:15147505"}}},{"start":1858,"length":24,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/lnkd.in\/gTbTMdcd"}}}],"text":"Our article on function-first T-cell receptor (TCR) discovery is now published in Proceedings of the National Academy of Sciences. We sort T cells by both (1) their ability to bind to peptide presented by major histocompatibility complex I (p-MHC) and (2) the induction of cytokine secretion. #Nanovials are used as artificial antigen-presenting cells as well as tiny test tubes to capture secretions from each activated T cell. The T-cell-containing nanovials are sorted with a standard flow sorter (Sony Biotechnology Inc. SH800S). Following sorting, matched alpha\/beta TCR sequences are recovered through single-cell RNA-seq using instruments and chips from 10x Genomics. Because we use oligo-barcoded antibodies to detect secretions (from BioLegend) we also can rank recovered TCR sequences based on the amount of cytokines secreted by the corresponding T cells.\n\nWhen ranking TCRs based on the amount of granzyme B secreted we had an dramatically increased yield of functional TCRs upon re-expression of the construct in T cells and exposure to antigen-presenting cells. These cells were often not the cells that were the most abundant clones.\n\nOur aim is to make TCR discovery yield highly functional TCR constructs for engineered #celltherapies and increase accessibility by leveraging standard equipment. Nanovials are available from Partillion Bioscience. \n\n#celltherapy #biotechnology #tcells #immunotherapy #TCRs #labonaparticle #cytometry #flowcytometry #singlecell #functionfirst\n\nCongratulations to Doyeon Felis Koo and Zhiyuan Mao for taking the lead along with a fantastic collaboration with Owen Witte. Many thanks to Joe de Rutte, Robert Dimatteo, Sohyung Lee, Natalie Tsubamoto, Miyako Noguchi, and many more contributors! Many thanks to the National Cancer Institute (NCI) IMAT program and Tony Dickherber, who helped support this work.\n\nhttps:\/\/lnkd.in\/gTbTMdcd"},"entityUrn":"urn:li:share:7178865756560920576"},"entityUrn":"urn:li:share:7178931521997733888"}}},{"createdAt":1716075000000,"insightId":"edad66b0-a3d1-460f-99fc-b2e18972f1a4","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7196290684616609792,7197740346439553026)","threadUrn":"urn:li:ugcPost:7196290684616609792","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":19,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:320353572"}}}],"text":"Sushmitha Sriramulu thank you \ud83d\ude4f and best of luck for your paper"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7196290684616609792"}}},{"createdAt":1716074940000,"insightId":"77a79859-26d4-4462-9507-8d1f8bfffff0","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7196290684616609792,7197740086522765312)","threadUrn":"urn:li:ugcPost:7196290684616609792","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":8,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:844568898"}}}],"text":"Anh Tran thank you \ud83d\ude4f"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7196290684616609792"}}},{"createdAt":1716074940000,"insightId":"d24773a3-ea5e-445a-9d3a-f35353427af2","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7196290684616609792,7197740049352777729)","threadUrn":"urn:li:ugcPost:7196290684616609792","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":32,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:102058691"}}}],"text":"Rakhee Rathnam Kalari Kandy, PhD thank you \ud83d\ude4f"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7196290684616609792"}}},{"createdAt":1716074940000,"insightId":"5aadeb6e-7a8a-4806-bd27-6afc9bc5ecc7","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7196290684616609792,7197740142462197760)","threadUrn":"urn:li:ugcPost:7196290684616609792","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:506224419"}}}],"text":"Kajal Kamra thank you \ud83d\ude4f talk with you soon"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7196290684616609792"}}},{"createdAt":1715182260000,"insightId":"5aa16824-5900-4fcc-8615-6ab45f95056b","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":4}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7193977493383430145,7193995868193112064)","threadUrn":"urn:li:activity:7193977493383430145","reactionsCount":4,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Thanks for asking us. Here are are some point: 1: timeline of the research and plan for publication. Story never end, but a decent and clear story need  be published on time. A clear plan and stick to the plan will help student for starting career while support grant application for both student fellowship and US R level funding. 2: what the student want to do in future and what the mentors can offer for them. The mentors need to show mentee the life lessons then learn from their own experience, Good, bad both. what might be a good direction to go. If you wanna go this direction, what the pros and cons are. What name you might be interested to search and approach to. I think in these discussions, mentor also learned form the mentee and clear their own understanding of the research field and the prosperous directions. 3: what the mentee might lack in the research they perform now and in the future and potential training plans."},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7193977493383430145"}}},{"createdAt":1715180100000,"insightId":"8f86be09-27e2-4330-a2b8-73bbb58a7f01","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193986809574428673)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":7,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:695737541"}}}],"text":"Yaru Xu thank you \ud83d\ude4f\ud83d\ude4f\ud83d\ude4f\ud83d\ude4fyou surely did fantastic job for that CD paper! \ud83d\udc4f\ud83d\udc4f\ud83d\udc4fkeep in touch"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}},{"createdAt":1715180040000,"insightId":"7bc60d9a-c742-4e76-9a0a-762b0f5c0ffe","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193986610030391299)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":13,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:897320230"}}}],"text":"Farhana Islam thank you \ud83d\ude4f\ud83d\ude4f\ud83d\ude4f we will rock GCT \ud83d\udcaa\ud83d\udcaa\ud83d\udcaa"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}},{"createdAt":1715179980000,"insightId":"28426818-f3f8-4abc-9f7c-389ed7463336","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193986412801634304)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":11,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:642911004"}}}],"text":"Neha Kumari thank you \ud83d\ude4f\ud83d\ude4f\ud83d\ude4fI know you will do good \ud83d\udc4d! Best wishes"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}},{"createdAt":1715179920000,"insightId":"0c274e79-692a-4733-8755-9dbde745f36b","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193986161797746689)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":19,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:320353572"}}}],"text":"Sushmitha Sriramulu thank you \ud83d\ude4f\ud83d\ude4f\ud83d\ude4fit\u2019s great to meet you at AACR! keep in touch and best wishes for your research \ud83e\udd1d\ud83e\udd1d\ud83e\udd1d"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}},{"createdAt":1715179920000,"insightId":"253f3e70-617f-4a3e-bf21-c63d1ebb42a2","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193986215040196608)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":66,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:1103715992"}}}],"text":"Palanisamy Nallasamy, Ph.D., Research Instructor-Oncology Research thank you \ud83d\ude4f\ud83d\ude4f"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}},{"createdAt":1715179860000,"insightId":"6f1dd535-36be-454e-87a5-3af7fe969c2e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193985859950448640)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":12,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:44637114"}}},{"start":41,"length":12,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:2374672"}}}],"text":"Sasha Forsen thank you \ud83d\ude4f\ud83d\ude4f\ud83d\ude4fthe time in Bio Nebraska is definitely one important part of this journey! I am privileged to joined this community \ud83e\udd1d\ud83e\udd1d\ud83e\udd1d"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}},{"createdAt":1715179740000,"insightId":"469fe30f-53d5-4bf2-8110-8cc4c5a9a3b0","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193985326887890944)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:40032990"}}}],"text":"Kathy DelGiorno thank you! \ud83d\ude4f\ud83d\ude4f\ud83d\ude4fHope to see you soon \ud83e\udd1d\ud83e\udd1d\ud83e\udd1d"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}},{"createdAt":1715179740000,"insightId":"7153af26-3261-4ec3-85d3-db4a887e5cc6","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193985465190866944)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":22,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:612848069"}}}],"text":"Bhuvaneshwari Seshadri thank you \ud83d\ude4f\ud83d\ude4f\ud83d\ude4fall the best for your career success"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}},{"createdAt":1715179680000,"insightId":"f874a0e3-f192-489a-a64d-f39f1321cb05","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(ugcPost:7193416793997086721,7193985168213176323)","threadUrn":"urn:li:ugcPost:7193416793997086721","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:115486925"}}}],"text":"Seema Parte,PhD thank you Seema \ud83d\ude4f\ud83d\ude4ffor sure I will talk with you sometime soon"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7193416793997086721"}}}]}